Terbutaline: Difference between revisions
| Line 42: | Line 42: | ||
==Sources== | ==Sources== | ||
Lexicomp | |||
<references/> | <references/> | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 00:49, 23 May 2015
General
- Type: Beta 2 agonist
- Dosage Forms: 1 mg/mL injection
Adult Dosing
Preterm labor
- 0.25mg sq q20-30 min, up to 4 doses PRN contractions
Asthma/Bronchoconstriction
- 0.25mg sq q20 min, up to 3 doses
Pediatric Dosing
Asthma/Bronchoconstriction
- 0.005-0.01 mg/kg to max 0.4 mg SQ q15-20 min, up to 3 doses; may repeat in 2-6 hours
Special Populations
- Pregnancy Rating: Category C
- Lactation: Not recommended
- Renal Dosing: n/a
- Hepatic Dosing: n/a
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Black box warning against prolonged use for tocolysis (>48-72 hrs)
- Cardiac arrhythmia
Common
- Agitation, tremor, hyperglycemia, hypokalemia
Pharmacology
- Onset: 6-15 minutes
- Half-life: 11-16 hours
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action: Beta 2 agonist, smooth muscle relaxant
See Also
Sources
Lexicomp
